Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2017-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of long-term treatment with
alogliptin (Nesina) in patients with mild type 2 diabetes mellitus in the routine clinical
setting.